Navigation Links
Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results
Date:11/5/2007

2) (3)

---------- ----------- ----------

Markets

California - Los Angeles Metro $696 70.8% 70.8%

California - San Diego 43,662 94.6 89.9

California - San Francisco Bay 64,415 95.1 96.7

Eastern Massachusetts 96,168 96.0 95.7

International - Canada 6,676 100.0 100.0

New Jersey/Suburban Philadelphia 8,524 96.3 96.6

Southeast 10,561 87.3(4) 86.2(4)

Suburban Washington D.C. 49,151 92.3 90.4

Washington - Seattle 30,630 93.4 93.7

-------- ------ ---------

Total Properties (Continuing

Operations) $310,483 94.1% 93.3%

======== ====== =========

(1) Excludes spaces at properties totaling 795,202 square feet undergoing

a permanent change in use to office/laboratory space through

redevelopment and one property totaling 49,437 square feet that is

classified as "held for sale."

(2) Including spaces undergoing a permanent change in use to

office/laboratory space through redevelopment, occupancy as of

September 30, 2007 was 87.4%. See page 16 for additional information

on our redevelopment program.

(3) Excludes spaces at properties totaling 812,785 square feet undergoing

a permanent change in use to office/laboratory space through

redevelopment. Including spaces undergoing a permanent change in use

to office/laboratory space through redevelopment, occupancy as of June

30, 2007 was 86.3%. See page 16 for additional information on our


'/>"/>
SOURCE Alexandria Real Estate Equities, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Coherent Announces Restatement Related to Stock-Based Compensation
2. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2010)... testing, is taking strides to expand their Product and Material Testing ... ... Minneapolis, MN (PRWEB) March 12, 2010 -- DDL , ... strides to expand their Product and Material Testing Division by promoting ... helping medical device manufacturers get to market for almost 20 years. ...
(Date:3/12/2010)... , ... , , ... ... ... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) today announced that it will restate its 2008 financial statements contained in its Annual Report on Form 10-K ...
(Date:3/11/2010)... and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of ... ... , ... ... ...
(Date:3/11/2010)... 11 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc. (NYSE Alternext: TPI), ... in Chengdu, China , today,announced it will present at ... held March 15-17, 2010 in Dana Point, ... Date: Tuesday, March 16, ... 10:30 AM PST (Track 3), Location: ...
Breaking Biology Technology:DDL Expands the Product & Material Testing Division 2DDL Expands the Product & Material Testing Division 3Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 2Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 3Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 4Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 5Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 6Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 7Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 8Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 9Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 10FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 2FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 5FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 6FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 7FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 8Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16 2Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16 3Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16 4
... Inc. (Nasdaq: NSTK ) announced today that ... further reduce operating expenses and,align the company,s workforce ... "The workforce reduction of approximately 50 employees will ... RNAi programs forward in a more,efficient manner for ...
... Larry G. Pickering Resigns from the Board of Directors, ... announced,the appointment of K. Tucker Andersen as a director ... Mr. Andersen is a retired,portfolio manager and security analyst ... Advisors, LLC. The Company also announced that on,February 1, ...
... - Halogen Software Inc., a leading,provider of web-based ... 2007 marked another record year in sales with ... included record,revenue with the company closing nearly 200 ... provides enterprise-level functionality to,organizations of all sizes, as ...
Other Biology Technology:Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring 2PeriCor Therapeutics Appoints K. Tucker Andersen to Board of Directors 2Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition 2Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition 3
(Date:3/11/2010)... A $6 million grant from the National Heart, Lung ... ORBIT: Obesity Related Behavioral Intervention Trials to focus on ... African-American and Latino communities. , ... disproportionately affected by the obesity epidemic, and its related ... Charlson, the center,s director, the William T. Foley Distinguished ...
(Date:3/11/2010)... gun to better manage their disease by controlling their ... sticky wicket of needing treatment that makes them hungry, ... levels and prevent weight gain may suggest an eating ... blame, said Dr. Deborah Young-Hyman, pediatric psychologist at the ... "You can,t use the same criteria to diagnose eating ...
(Date:3/11/2010)... Wisconsin-Madison have designed a way to harvest small amounts ... into usable hydrogen fuel. , The process is simple, ... , "This study provides a simple and cost-effective technology ... by scavenging energy wastes such as noise or stray ... new paper, published March 2 in the Journal ...
Breaking Biology News(10 mins):Center aims to cut obesity in black, Latino New Yorkers 2Center aims to cut obesity in black, Latino New Yorkers 3Diabetes' link to eating disorders explored 2Diabetes' link to eating disorders explored 3Scavenging energy waste to turn water into hydrogen fuel 2New tool in the fight against mosquito borne disease 3A A microbial mosquito net 11260 1New tool in the fight against mosquito borne disease 3A A microbial mosquito net 11260 2Statement from Larry Minnix CEO American Association of Homes and Services for the Aging On the Senates Passage of Health Reform Legislation 63896 1Senate Action Part of Long Road to Health Care Reform 63892 1Senate Action Part of Long Road to Health Care Reform 63892 2
... This release is available in French . ... 2009 recipients of E.W.R. Steacie Memorial Fellowships. Dr. Andrew ... Biology and the Redpath Museum, and Dr. Karim Nader, ... Department of Psychology, will both receive the prestigious fellowships ...
... of the ongoing mission to train and educate scientists ... the J. Craig Venter Institute,s (JCVI) Eukaryotic Genome Annotation ... 3rd-5th to train 40 United States Agriculture Department (USDA) ... training session will focus on the use of JCVI,s ...
... has completed the first successful demonstration of a noninvasive ... with acute stroke, a leading cause of disability and ... to improve the management of patients with stroke and ... brain blood flow and metabolism. , "Our preliminary study ...
Other Biology News:2 McGill researchers garner prestigious NSERC Steacie Fellowships 2JCVI program trains USDA scientists on eukaryotic genome analysis 2Penn research team tests bedside monitoring of brain blood flow and metabolism in stroke victims 2
CMRL Medium-1066 (1X) liquid...
... biosynthesized by the 11(R)-LOs of the ... fresh water hydra, H. vulgaris. The ... oocyte maturation and tentacle regeneration, respectively, ... produced when aspirin-treated recombinant COX-2 is ...
... (PEBP) does not share significant homology ... PEBP is expressed in the central ... and stomach. One important role ... inhibitory activity against several serine proteases ...
... The PowerEase 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple intuitive ...
Biology Products: